About Annovis Bio (ANVS)
Annovis Bio, Inc. operates as a biotechnology company. The Company develops drugs for alzheimer's and parkinson's disease, including the orphan indication dementia and alzheimer's in down syndrome. Annovis Bio serves customers in the State of Pennsyl... Read more
- USD9.44
- USD9.56
- USD9.26
- USD23.89
- -22.70%
- --
- 24.43k
- 43.53k
- 89M
- 9.26
- -30.50%
Stock News
yesterday
: Government shutdown: Video reportedly shows Rep. Jamaal Bowman pulling fire alarm as House scrambles to vote on spending bill
MarketWatch
yesterday
Commodities Corner: Why gasoline prices are set to fall even as oil marches toward $100 a barrel
MarketWatch
yesterday
Living With Climate Change: Here’s how El Niño will impact winter, including skiing and snowboarding plans
MarketWatch
yesterday
These are the top 4 Club stocks — and the bottom 4 — during the third quarter
CNBC
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
